Longsha Capsules and Health Ingredients (CHI) has added new capsule production lines at its factories in Suzhou, China and Ravali, India, demonstrating its long-term strategic commitment to this business segment and the Asia Pacific region. This expansion aims to balance CHI's global layout, meet regional demand, and promote technological upgrades.

Basel, Switzerland, December 19, 2024- Lonza Group, as a manufacturing partner in the global pharmaceutical, biotechnology, and nutritional health markets, announced that its factories in Suzhou, China and Ravali, India will undergo capacity expansion. The expansion project includes the addition of a gelatin hollow capsule (HGC) production line to support the production of high-quality gelatin hard capsules. The types of capsules produced cover both conventional and customized capsules required by the pharmaceutical and nutritional health products industries. This capacity expansion marks another important progress in Longsha CHI's hollow hard capsule strategy, aimed at enhancing long-term competitiveness and meeting high quality and sustainability standards.

Gelatin hollow capsules are powerful and versatile capsules that can meet various application needs in the pharmaceutical and nutritional health product markets by encapsulating liquid or solid fillers. Starting from the fourth quarter of 2024, new production lines have been put into operation at the Suzhou and Lavari factories, and another production line is planned to be put into operation in the third quarter of 2025. The increased production capacity this time aims to enhance Longsha CHI's product supply capability, meet regional market demand, and promote innovation.

The highly automated advanced production line is capable of producing capsules in various specifications and colors, and follows strict raw material and product control standards. The newly established high-end advanced production line in the Asia Pacific region aims to increase overall annual production capacity and ensure the production of high-quality capsules.

Aanchal Tomar, Business Head of Longsha Capsules and Health Ingredients Asia Pacific, said, "Gelatin hard capsules are an important pharmaceutical formulation that is widely favored by patients and consumers due to their ease of swallowing, good taste and odor masking effects. With their excellent dissolution rate, these capsules are of great value to developers of drugs and nutritional supplements. As we add production lines to our factories in India and China, we are continuously improving our product supply capacity and production capacity to help customers succeed in developing innovative solutions and drugs in the Asia Pacific region. By increasing production capacity, we aim to provide our partners with more flexible and reliable services.”

Source: https://pharm.jgvogel.cn/c1477072.shtml